» Articles » PMID: 3036495

Identification of the HPV-16 E6 Protein from Transformed Mouse Cells and Human Cervical Carcinoma Cell Lines

Overview
Journal EMBO J
Date 1987 Apr 1
PMID 3036495
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Human cervical carcinoma cell lines that harbor human papillomavirus (HPV) have been reported to retain selectively and express HPV sequences which could encode viral E6 and E7 proteins. The potential importance of HPV E6 to tumors is suggested further by the observation that bovine papillomavirus (BPV) E6 can induce morphologic transformation of mouse cells in vitro. To identify HPV E6 protein, a polypeptide encoded by HPV-16 E6 was produced in a bacterial expression vector and used to raise antisera. The antisera specifically immunoprecipitated the predicted 18-kd protein in two human carcinoma cell lines known to express HPV-16 RNA and in mouse cells morphologically transformed by HPV-16 DNA. The 18-kd E6 protein was distinct from a previously identified HPV-16 E7 protein. The HPV-16 E6 antibodies were found to be type specific in that they did not recognize E6 protein in cells containing HPV-18 sequences and reacted weakly, if at all, to BPV E6 protein. The results demonstrate that human tumors containing HPV-16 DNA can express an E6 protein product. They are consistent with the hypothesis that E6 may contribute to the transformed phenotype in human cervical cancers that express this protein.

Citing Articles

Too many cooks in the kitchen: HPV driven carcinogenesis - The result of collaboration or competition?.

Kathleen W Tumour Virus Res. 2024; 19():200311.

PMID: 39733972 PMC: 11753912. DOI: 10.1016/j.tvr.2024.200311.


Androgens in cervical cancer: Their role in epidemiology and biology.

Gu Y, Mu Q, Cheng D iScience. 2024; 27(7):110155.

PMID: 39021790 PMC: 11253156. DOI: 10.1016/j.isci.2024.110155.


Identification of HPV oncogene and host cell differentiation associated cellular heterogeneity in cervical cancer via single-cell transcriptomic analysis.

Li Y, Wang C, Ma A, Rani A, Luo M, Li J bioRxiv. 2023; .

PMID: 37645794 PMC: 10462038. DOI: 10.1101/2023.08.10.552878.


AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.

Miller J, Dakic A, Spurgeon M, Saenz F, Kallakury B, Zhao B J Med Virol. 2022; 94(8):3962-3977.

PMID: 35437795 PMC: 9199254. DOI: 10.1002/jmv.27795.


Molecular pathways in the development of HPV-induced cervical cancer.

Rasi Bonab F, Baghbanzadeh A, Ghaseminia M, Bolandi N, Mokhtarzadeh A, Amini M EXCLI J. 2021; 20:320-337.

PMID: 33746665 PMC: 7975633. DOI: 10.17179/excli2021-3365.


References
1.
Crum C, Ikenberg H, Richart R, Gissman L . Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med. 1984; 310(14):880-3. DOI: 10.1056/NEJM198404053101403. View

2.
Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H . A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984; 3(5):1151-7. PMC: 557488. DOI: 10.1002/j.1460-2075.1984.tb01944.x. View

3.
Schiller J, Vass W, Lowy D . Identification of a second transforming region in bovine papillomavirus DNA. Proc Natl Acad Sci U S A. 1984; 81(24):7880-4. PMC: 392256. DOI: 10.1073/pnas.81.24.7880. View

4.
Lusky M, Botchan M . Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors. J Virol. 1985; 53(3):955-65. PMC: 254732. DOI: 10.1128/JVI.53.3.955-965.1985. View

5.
Schwarz E, Freese U, Gissmann L, Mayer W, Roggenbuck B, Stremlau A . Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985; 314(6006):111-4. DOI: 10.1038/314111a0. View